Advance Zinctek Limited · ASX:ANO
Advance Zinctek — Investor Presentation (January 2019)
17 slides from Advance Zinctek's investor presentation, Jan 30, 2019
Slide 1: Appendix 4D – Interim Financial Report for Half Year Ended 31 December 2018
Appendix 4D Interim Financial Report _________________________________________________________________________________________________________________ Appendix 4D – Interim Financial Report for Half Year Ended 31 December 2018 ABN 54 079 845 855 Name of Entity: ADVANCE NANOTEK LIMITED ABN: 54 079 84
Slide 2: ANO Investor Presentation
ANO Investor Presentation February 2019 ANO Powder Performance versus Competitors
Slide 3: ANO Share Price
ANO Share Price 1.6 6000000 1.4 5000000 1.2 Net Profit ($) Share Price ($) 4000000 1 $3,006,918 0.8 3000000 0.6 2000000 0.4 1000000 0.2 $561,174 -$119,868 0 0 -1000000 Date (dd/mm/yy) • Appointment of Geoff Acton Managing Director on 16th March 2016. 1
Slide 4: Revenue Growth ($)
Total Annual Sales Revenue by Product Category ($ ‘000) $12.000 $10.600 $10.000 Revenue Growth ($) $8.000 $8.500 $6.583 $6.000 $4.284 $4.521 $3.723 $4.058 $3.892 $5.348 $4.000 $3.273 $2.937 $4.075 $1.949 $3.565 $2.100 $2.000 $1.121 $1.230 $1.010 $1.774 $0.327 $0.445 $- 2013 2014 2015 2016 2017 2018
Slide 5: ANO Total Operating Costs (Including Wages)
ANO Total Operating Costs (Including Wages) ($) Excluding Raw Materials and Consumables $3,600,000 $3,500,000 $3,400,000 $3,282,408 Total Operating Cost ($) $3,200,000 $3,000,000 $2,875,851 $2,800,000 $2,633,294 $2,600,000 $2,592,220 $2,410,616 $2,400,000 $2,200,000 $2,036,908 $2,000,000 2013 2014 2
Slide 6: Wages as a % of Sales Revenue
Wages as a % of Sales Revenue 35.00% 30.27% 30.00% 27.14% 25.00% 21.33% 21.82% Wages (%) 20.00% 15.00% 11.89% 13.07% 9.76% 10.00% 5.00% 2013 2014 2015 2016 2017 2018 2018-19 Projection Year 2013 2014 2015 2016 2017 2018 2018-19 Projection • Decrease in wages as a % of sales revenue despite the incre
Slide 7: Anticipated Reinstatement of Deferred Tax Asset Balance
Anticipated Reinstatement of Deferred Tax Asset (DTA) Balance 2500000 $2.25m $2.4m 2000000 $1.75m 1500000 $1.5m Net Profit ($) 1000000 500000 0 2018 2019 2020 2021 Year 2018 2019 2020 2021 • Anticipated franked dividends to commence in FY22 or earlier. • The Board will bring back the DTA in line wit
Slide 8: Number of Overseas Distributors and Resellers
Number of Overseas Distributors and Resellers 25 23 Number of Overseas Distributors 20 19 14 15 12 15 12 or Resellers 11 11 11 10 10 9 7 11 9 9 9 6 5 4 2 2 2 0 2013 2014 2015 2016 2017 2018 2018-19 Projection Year Distributors Resellers Total GLOBAL SALES NETWORK TARGETS • Connell Brothers India – •
Slide 9: ANO R&D Costs and Number of Formulations and Products Being Developed
ANO R&D Costs and Number of Formulations and Products Being Developed 70 $1,600,000 Number of Formulations Developed or $1,381,510 60 60 $1,400,000 51 $1,200,000 50 being developed $950,000 RnD Costs ($) 40 $1,000,000 40 $831,357 $800,000 30 $600,000 $641,382 $619,003 20 $563,000 $400,000 10 $200,00
Slide 10: ANO R&D - Battery Testing Update
ANO R&D - Battery Testing Update • UQ trials using on our patented material and process developed coin cell batteries that produced 3000 cycles versus 2000 cycles for the average life of batteries based on similar materials. • Currently working with Custom Cells in Germany on one battery project. •
Slide 11: Number of Chemists Supporting our Products
Number of Chemists Supporting our Products 60 50 50 Number of Chemists 40 32 30 27 20 10 4 3 3 3 5 5 2 0 2013 2014 2015 2016 2017 2018 2019 Projection Year External Chemists Supporting our products Internal Chemists Supporting our products • The unique nature of our product and difficulties in produ
Slide 12: Number of New Patents Developed
Number of New Patents Developed Number of New Patents Developed 7 6 6 5 4 4 3 3 2 2 1 0 0 0 0 0 2013 2014 2015 2016 2017 2018 Dec 2018 2018-19 Year Projection 2013 2014 2015 2016 2017 2018 Dec 2018 2018-19 Projection • 4 new patents filed already in FY19. Further new patents expected. • Patent renew
Slide 13: Reef Safe Sunscreen
Reef Safe Sunscreen • ANO has submitted a proposal to the Great Barrier Reef Foundation and the Cassowary Coast Council to discourage the use of reef harmful UV absorber chemical based sunscreens. • Follows the lead of Hawaii who have banned the use of chemical sunscreens on their beaches. Hawaii Ba
Slide 14: Reef Safe Statement References
Reef Safe Statement References Written by Mark Chandler, BA Chemistry Reviewed by Professor Julian Hewitt https://www.ewg.org/sunscreen/report/nanoparticles-in- https://www.sciencedirect.com/science/article/pii/S0043135407003 sunscreen/#.WuOKSMgvyUk 417 https://www.ncbi.nlm.nih.gov/pubmed/19902187 h
Slide 15: Diversification and Product Development
Diversification and Product Development 2019 / 2020 • Board and Management are very aware that we only have four (4) profitable product lines contributing to our current success. • Zinxation sunscreen sales should positively impact sales in this half FY19. • Every effort is being made to develop new
Slide 16: Foundations Laid by Previous Board
Foundations Laid by Previous Board • The current Board thanks the hard work and due diligence of Rade Dudurovic, Ron Higham, and Paul Pissale in 2014 / 2015 who, under Rade’s direction, plotted the strategic direction and initiated the start of the renewal process which now underpins the current suc
Slide 17: Disclaimer
Disclaimer Management of Advance NanoTek Ltd (ABN 54 079 845 855) and its subsidiaries (collectively ‘ANO’) has made every effort to ensure the accuracy of the information contained in this presentation. The presentation has been prepared based on information available prior to the date of this pres
Advance Zinctek — Investor Presentation (January 2019) on 6ix